Atea Pharmaceuticals
AVIR
AVIR
118 hedge funds and large institutions have $171M invested in Atea Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 44 increasing their positions, 41 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
-14
Holders Change %
-10.61%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
44
Reduced
41
Closed
20
Calls
$260K
Puts
$78K
Net Calls
+$182K
Net Calls Change
+$88K
Top Buyers
1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
$14.4M |
2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$5.16M |
3 |
TCM
Tang Capital Management
San Diego,
California
|
$10.8M |
4 |
BlackRock
New York
|
$24.6M |
5 |
NM
Newtyn Management
New York
|
$1.2M |